TARO PHARMACEUTICAL INDUSTRIES LTD
DelistedCIK 906338fmd_0AD4ZM7V0TTABS8GVN0VAAE3FAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2023, 16 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 759 | 863 | 951 | 879 | 662 | 670 | 645 | 549 | 561 | 573 |
| Cost of revenue | 179 | 186 | 170 | 208 | 198 | 224 | 245 | 252 | 268 | 305 |
| Gross profit | 580 | 677 | 779 | 671 | 464 | 446 | 400 | 297 | 293 | 268 |
| Research and development | 55 | 66 | 71 | 71 | 70 | 63 | 60 | 60 | 55 | 52 |
| Selling, general and administrative | 92 | 88 | 92 | 86 | 88 | 90 | 93 | 91 | 114 | 198 |
| Total operating expenses | 150 | 149 | 164 | 156 | 160 | 150 | 153 | 710 | 230 | 251 |
| Operating income | 430 | 528 | 614 | 515 | 303 | 296 | 247 | (414) | 63 | 18 |
| Other non-operating income (expense) | 12 | 51 | 20 | 35 | (13) | 59 | 48 | 20 | 10 | 18 |
| Income before taxes | 444 | 582 | 637 | 561 | 292 | 357 | 298 | (391) | 78 | 38 |
| Income tax expense | 83 | 96 | 95 | 104 | 82 | 75 | 53 | 10 | 20 | 13 |
| Net income from continuing operations | 361 | 486 | 542 | 457 | 210 | 282 | 245 | (401) | 58 | 25 |
| Net income | 360 | 484 | 541 | 456 | 211 | 282 | 244 | (387) | 58 | 25 |